From: The pathology of small airways disease in COPD: historical aspects and future directions
Authors | Key findings | Area of quantification / Type of analysis | Patient groups | |||||
---|---|---|---|---|---|---|---|---|
Macrophages | Neutrophils | CD3+ | CD4+ | CD8+ | CD20+ | |||
Saetta et al. 1998 [76] | = | = | NQ | = | ↑ | NQ | Sub-epithelium excluding smooth muscle | COPD vs S |
Saetta et al. 2000 [59] | ↑ | = | NQ | = | ↑ | NQ | Intra-epithelium | COPD vs NS |
Turato et al. 2002 [77] | a↑ | = | NQ | b↑ | b↑ | NQ | aIntra- and bsub-epithelium | GOLD 3 vs S and GOLD 1 |
Hogg et al. 2004 [22] | a↑ | a↑ | NQ | a↑ | a, b↑ | a, b↑ | aNumber of airways +ve for cell type bAccumulated volume | Increasing severity of disease |
Baraldo et al. 2004 [82] | = | a, b↑ | NQ | = | a, b↑ | NQ | aWithin smooth muscle bpercentage of airways +ve for cell type | COPD vs NS |
Pilette et al. 2007 [80] | = | ↑ | ↑ | NQ | NQ | NQ | Intra-epithelium and lamina propria | COPD vs S |
Battaglia et al. 2007 [83] | = | a↑ | = | = | = | NQ | Lamina propria adid not reach significance | COPD vs S |
Kim et al. 2008 [84] | = | = | ↑ | = | = | NQ | Intra- and sub-epithelium | GOLD 4 vs GOLD 0 |
Olloquequi et al. 2010 [81] | NQ | NQ | = | = | ↑ | = | Intra- and sub-epithelium | GOLD2 vs NS |
Isajevs et al. 2011[79] | ↑ | ↑ | NQ | NQ | ↑ | NQ | Intra- and sub-epithelium | COPD vs NS |
Polosukhin et al. 2011 [27] | NQ | NQ | NQ | = | ↑ | NQ | Intra- and sub-epithelial | COPD vs NS |
Polosukhin et al. 2017 [26] | ↑ | ↑ | NQ | NQ | NQ | NQ | Sub-epithelium | COPD vs NS GOLD 3/4 vs GOLD 1/2 |
Eapen et al. 2017 [78] | = | = | NQ | NQ | ↑ | NQ | Sub-epithelium | COPD vs NS |